PMID- 27726307 OWN - NLM STAT- MEDLINE DCOM- 20170926 LR - 20171128 IS - 1520-7560 (Electronic) IS - 1520-7552 (Linking) VI - 33 IP - 3 DP - 2017 Mar TI - High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes. LID - 10.1002/dmrr.2864 [doi] AB - BACKGROUND: The incidence of type 1 diabetes mellitus (T1DM) in Sardinia is among the highest in the world (44.8 cases/100,000 person-years). Recommendations of the Immunology of Diabetes Society advise evaluating autoantibody positivity in first-degree relatives (FDRs) of patients with T1DM, for their higher risk to develop the disease. The aim of this study was to determine the prevalence of beta-cell autoimmunity in FDRs of T1DM patients in Sardinia. METHODS: A total of 188 Sardinian families were recruited in collaboration between diabetes and pediatric units of university and district hospitals in Sardinia. The recruitment involved 188 patients with diagnosed T1DM and all their available FDRs (n = 447). Autoantibodies (Aabs) against GAD, IA2, insulin, and ZnT8 were measured in all subjects. Human leukocyte antigen (HLA) risk genotypes (HLA-DR and DQ loci) were analyzed in 43 Aabs-positive FDR. RESULTS: The prevalence of Aabs (any type of autoantibody, single or multiple) in FDR was 11.9% (53/447). Of those with autoantibodies, 62.3% (33/53) were positive to only 1 autoantibody, 22.6% (12/53) had 2 autoantibodies, 7.55% (4/53) had 3 autoantibodies, and 7.55% (4/53) had all 4 autoantibodies. Typing of HLA-DR and DQ loci showed that 89% of FDR carried moderate- to high-risk genotypes, with only 5 FDR with low-risk genotypes. CONCLUSIONS: The prevalence of T1DM autoantibodies in FDRs of T1DM patients was very high (11.9%) in the Sardinian population, higher than in other populations from the United States and Europe, and similar to that observed in Finland. Autoantibody positivity strongly associated with HLA risk. This study provides evidence of the high risk of T1DM in FDR of T1DM patients in Sardinia and warrants longitudinal follow-up to estimate the risk of progression to T1DM in high-risk populations. CI - Copyright (c) 2016 John Wiley & Sons, Ltd. FAU - Incani, M AU - Incani M AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Serafini, C AU - Serafini C AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Satta, C AU - Satta C AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Perra, L AU - Perra L AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Scano, F AU - Scano F AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Frongia, P AU - Frongia P AD - Paediatric Unit, San Michele Hospital, Cagliari, Italy. FAU - Ricciardi, R AU - Ricciardi R AD - Paediatric Unit, San Michele Hospital, Cagliari, Italy. FAU - Ripoli, C AU - Ripoli C AD - Diabetes Paediatric Unit, San Michele Hospital, Cagliari, Italy. FAU - Soro, M AU - Soro M AD - Paediatric Unit, San Martino Hospital, Oristano, Italy. FAU - Strazzera, A AU - Strazzera A AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Zampetti, S AU - Zampetti S AD - Endocrinology, Department Experimental Medicine, Sapienza University of Rome, Italy. FAU - Buzzetti, R AU - Buzzetti R AD - Endocrinology, Department Experimental Medicine, Sapienza University of Rome, Italy. FAU - Cavallo, M G AU - Cavallo MG AD - Internal Medicine Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy. FAU - Cossu, E AU - Cossu E AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. FAU - Baroni, M G AU - Baroni MG AUID- ORCID: 0000-0002-3224-6078 AD - Endocrinology and Diabetes, Department of Medical Sciences, University of Cagliari, Italy. AD - Endocrinology, Department Experimental Medicine, Sapienza University of Rome, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20161130 PL - England TA - Diabetes Metab Res Rev JT - Diabetes/metabolism research and reviews JID - 100883450 RN - 0 (Autoantibodies) RN - 0 (Biomarkers) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DR Antigens) SB - IM MH - Adolescent MH - Adult MH - Autoantibodies/*immunology MH - Autoimmune Diseases/*epidemiology/genetics/immunology MH - Autoimmunity/*immunology MH - Biomarkers/analysis MH - Child MH - Diabetes Mellitus, Type 1/*physiopathology MH - Family MH - Female MH - Follow-Up Studies MH - Genetic Predisposition to Disease MH - HLA-DQ Antigens/*immunology MH - HLA-DR Antigens/*immunology MH - Humans MH - Islets of Langerhans/*immunology MH - Italy/epidemiology MH - Male MH - Prevalence MH - Prognosis MH - Young Adult OTO - NOTNLM OT - HLA risk OT - Sardinia OT - Type 1 diabetes mellitus OT - autoantibodies OT - first-degree relatives EDAT- 2016/10/12 06:00 MHDA- 2017/09/28 06:00 CRDT- 2016/10/12 06:00 PHST- 2016/04/11 00:00 [received] PHST- 2016/09/16 00:00 [revised] PHST- 2016/10/07 00:00 [accepted] PHST- 2016/10/12 06:00 [pubmed] PHST- 2017/09/28 06:00 [medline] PHST- 2016/10/12 06:00 [entrez] AID - 10.1002/dmrr.2864 [doi] PST - ppublish SO - Diabetes Metab Res Rev. 2017 Mar;33(3). doi: 10.1002/dmrr.2864. Epub 2016 Nov 30.